U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 20-26, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 20-26, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

No Significant Event

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/23/2022
Location: Virtual
Subject: Association of Manufacturers and Distributors Food Safety Congress; Speaker: Food Safety Culture and Smarter Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Several hundred international food manufactures, distributors, food safety experts, and government officials

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/25/2022
Location: Virtual
Subject: Bio North Texas Rare Disease Roundtable
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Bio North Texas Rare Disease Roundtable Discussion

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/24/2022
Location: Virtual
Subject: Medical Device Single Review Program
FDA Participant/Group: ELLEN FLANNERY; MELISSA TORRES; ANGELA KRUEGER; ARIEL SEELEY;
Non FDA Participant/Group: Jennifer Paine, Phil Desjardins, Riley Swinehart, Robert Durgin, Tom Conniff (Johnson and Johnson);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 02/23/2022
Location: Virtual
Subject: Careers in Public Service, Role of FDA, Challenging and Vexing Legal and Regulatory Issues, Graphic Warnings, Menthol and Cigar Flavors
FDA Participant/Group: N/A
Non FDA Participant/Group: Students of the University of Pennsylvania Carey School of Law

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 02/24/2022
Location: Virtual
Subject: Generic Animal Drug Alliance (GADA) / CVM Triannual Meeting
FDA Participant/Group: MATTHEW LUCIA; TIMOTHY SCHELL; NEAL BATALLER;
Non FDA Participant/Group: Members of the Generic Animal Drug Alliance (GADA)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top